Close

BofA/Merrill Lynch Downgrades Karyopharm Therapeutics (KPTI) to Underperform

Go back to BofA/Merrill Lynch Downgrades Karyopharm Therapeutics (KPTI) to Underperform
KARYOPHARM THERAP (NASDAQ: KPTI) Delayed: 1.07 -0.02 (1.83%)
Previous Close $1.09    52 Week High $19.41 
Open $1.07    52 Week Low $4.83 
Day High $1.10    P/E N/A 
Day Low $1.03    EPS $-2.74 
Volume 392,966